About UBS FUND MANAGEMEN

UFUK invests in stocks. The fund's major sectors are Health Technology, with 33.20% stocks, and Finance, with 21.58% of the basket. The assets are mostly located in the Europe region.

UFUK top holdings are Nestle S.A. and Roche Holding Ltd Dividend Right Cert., occupying 14.38% and 11.87% of the portfolio correspondingly.

UFUK last dividends amounted to 0.38 CHF. The year before, the issuer paid 0.34 CHF in dividends, which shows a 10.53% increase.

UFUK assets under management is ‪1.48 B‬ CHF. It's fallen 0.80% over the last month.

UFUK fund flows account for ‪164.30 M‬ CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

UFUK shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Jul 18, 2011, and its management style is Passive.

UFUK expense ratio is 0.09% meaning you'd have to pay 0.09% of your investment to help manage the fund.

UFUK follows the Switzerland SPI. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

UFUK invests in stocks.

UFUK price has risen by 0.86% over the last month, and its yearly performance shows a −1.92% decrease. See more dynamics on UFUK price chart.
NAV returns, another gauge of an ETF dynamics, showed a 6.33% increase in three-month performance and has increased by 2.23% in a year.